Featured Research

from universities, journals, and other organizations

Solution To Collapsed Veins: Device May Replace Traditional IV In Wartime

Date:
March 24, 2003
Source:
University Of Texas Health Science Center At San Antonio
Summary:
It may not be in time to help U.S. and British soldiers now in harm's way inside Iraq, but a new device developed by the VidaCare Corp. and researchers at The University of Texas Health Science Center at San Antonio is certain to save our heroes' lives in future armed conflicts.

San Antonio (March 24, 2003) -- It may not be in time to help U.S. and British soldiers now in harm's way inside Iraq, but a new device developed by the VidaCare Corp. and researchers at The University of Texas Health Science Center at San Antonio is certain to save our heroes' lives in future armed conflicts.

As wounded soldiers go into shock, their veins fall, making a traditional IV very difficult to start. Without an infusion of fluids, blood or medicines, there's a strong chance they will die.

The "VidaPort" is a handheld, battery-powered device about the size and weight of a glue gun used in crafts. In a few seconds, it drills a small hollow needle through the bone to the marrow cavity, which has been called a non-collapsible vein. On the surface of the skin, a port connected to the needle provides instant, stable hookup to lifesaving fluids. The VidaPort utilizes a technique called intraosseous (IO) vascular access.

"When minutes and seconds matter, our soldiers need every tool they can get," said Francisco G. Cigarroa, M.D., president of the Health Science Center. "We are proud to be a partner in the development of this easy-to-use and revolutionary device."

"This is a critically needed technology that will save thousands of lives a year," said emergency medicine physician Larry J. Miller, M.D., chairman and CEO of VidaCare. "It solves a particular problem for our military. Medics in Special Operations generally operate at night. Most patients in such a theater have suffered life-threatening trauma. A study shows that on the average it takes a medic 12 minutes to start an IV. Lives are lost during that time because of the delay. Thanks to VidaPort, starting a line will take less than 10 seconds."

The medical community established years ago the effectiveness of administering blood transfusions, medicines and fluids through the bone marrow for infants who have collapsed veins due to shock. There has been no solution for adults because their bones are too hard to access the bone marrow.

The devices used in children are inserted manually. The VidaPort kit will come with an analgesic agent (lidocaine) to numb the area to the bone 30 seconds before insertion. The device can be inserted into the tibia (the shin bone) or arm. Most recipients would be suffering from shock or unconscious.

Emphasis on homeland security is sure to make the VidaPort a timely weapon in combating the effects of terrorism. The threat of mass exposures to biological weapons such as anthrax or ricin makes finding a quick, reliable way to start fluids and medications even more essential, said Harold L. Timboe, M.D., M.P.H., vice president for administration and director of the Center for Public Health Preparedness and Biomedical Research at the Health Science Center. "In a situation involving mass casualties, paramedics and other first responders will need this new technology," said Dr. Timboe, former commander of Brooke Army Medical Center and Walter Reed Army Medical Center. On September 11 he was commander of Walter Reed, which received casualties from the Pentagon attack.

Dr. Cigarroa announced the Health Science Center has entered its first equity agreement in lieu of royalties with VidaCare, which is developing and marketing the product worldwide. VidaCare and the Health Science Center are applying to the U.S. Food and Drug Administration for 510k approval, which is a 90-day process. VidaCare expects FDA approval by August of this year. The VidaPort driver is expected to sell for about $150 and the replaceable needles for about $95.


Story Source:

The above story is based on materials provided by University Of Texas Health Science Center At San Antonio. Note: Materials may be edited for content and length.


Cite This Page:

University Of Texas Health Science Center At San Antonio. "Solution To Collapsed Veins: Device May Replace Traditional IV In Wartime." ScienceDaily. ScienceDaily, 24 March 2003. <www.sciencedaily.com/releases/2003/03/030324064739.htm>.
University Of Texas Health Science Center At San Antonio. (2003, March 24). Solution To Collapsed Veins: Device May Replace Traditional IV In Wartime. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2003/03/030324064739.htm
University Of Texas Health Science Center At San Antonio. "Solution To Collapsed Veins: Device May Replace Traditional IV In Wartime." ScienceDaily. www.sciencedaily.com/releases/2003/03/030324064739.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins